Abstract:Objective To study the relationship between the chemokine CX3CL1/ CX3CR1 and platinum drug resistance, as well as prognosis in ovarian cancer patients. To dynamically detect the resistance nude mice model of CX3CL1 and its receptor CX3CR1 in the course of platinum resistance. To analyze the expression of CX3CL1, CX3CR1 and the correlation of Fas signaling pathway. Methods The cancer gene atlas(TCGA) database of patients with ovarian cancer genome-wide expression was employed to analyze the relation-ship of CX3CL1/ CX3CR1 in platinum sensitivity or resistant patients with clinical features. Ovarian cancer SKOV3 sensitive cells(SK-OV3-GFP) with green fluorescent marker and cisplatin resistant cells(SKOV3-GFP / DDPⅢ) were subcutaneously injected in nude mice. After xenograft was constracted, cisplatin was intraperitoneally injected. Real time fluorescence quantitative-PCR(qRT-PCR) was used to detect the expression of CX3CL1, CX3CR1 and genes on Fas signal pathway after 0, 2, 5, 8 times of cisplatin injection. Results CX3CL1 expression was negatively correlated with FIGO and platinum resistance(r=-0. 112,P= 0. 030;r=-0. 106,P= 0. 044), CX3CR1 expression was negatively correlated with progression-free survival time(r = -0. 130,P = 0. 029) and positively correlated with 1-year re-lapse rate(r= 0. 119,P = 0. 045). The average expression of CX3CL1 in platinum sensitive group was 3. 96±0. 039, higher than 3. 64± 0. 55 of platinum resistant group(P= 0. 000). After the intervention of cisplatin, xenograft grew gradually. The weight of xenograft in SK-OV3-GFP / DDPⅢ group was higher than SKOV3-GFP group, and xenograft in the both two groups shrank at the fifth time of infection. After cisplatin stimulation, the expression of CX3CL1/ CX3CR1 in SKOV3-GFP group increased significantly(P= 0. 001, P= 0. 002), but it remained low in SKOV3-GFP / DDPⅢ group. The expression of Fas and FADD of Fas signal pathway in SKOV3 GFP / DDPⅢ group was also significantly lower than them in SKOV3-GFP group(P<0. 001). However, PARP1 gene significantly rose in SKOV3GFP / DDPⅢgroup than that in SKOV3-GFP group(P<0. 001). The expression of CX3CL1 and CX3CR1 was positively correlated with Fas and FADD, while it was negatively correlated with PARP1 of Fas signaling pathways. Conclusion The down-regulation of CX3CL1 and CX3CR1 is associated with platinum resistance. They may play a role in maintain the sensitivity of tumor cells to platinum. The low expression of CX3CL1 and CX3CR1 may suppress Fas signal pathway through some mechanism, resulting in transduction disorder, inhibiting cell apop-tosis and inducing platinum resistance of ovarian cancer. The lower expression of drug-resistant cells may be a mechanism inhibiting Fas signaling pathways, which make its conduction misbalance, finally inhibiting cell apoptosis, inducing the resistance of ovarian cancer. It may be a platinum promote ovarian cancer therapy targeting molecules.

Downregulation Of Gpr4 And Tcf7 Promotes Apoptosis And Inhibits Growth And Invasion Of Ovarian Cancer Cells

CRMP4 Suppresses Cervical Cancer Cell Proliferation and EMT Through the Wnt/β-catenin Pathway

Down-Regulation Of Gli Transcription Factor Leads To The Inhibition Of Migration And Invasion Of Ovarian Cancer Cells Via Integrin Beta 4-Mediated Fak Signaling

Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor.

Long Noncoding RNA CTD-2589M5.4 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion Via Downregulation of the Extracellular Matrix-Receptor Interaction Pathway.

Effects and Mechanism of RhoC Downregulation in Suppressing Ovarian Cancer Stem Cell Proliferation, Drug Resistance, Invasion and Metastasis

Inhibition of TMEM45A Suppresses Proliferation, Induces Cell Cycle Arrest and Reduces Cell Invasion in Human Ovarian Cancer Cells.

Effects of ovarian cancer G protein coupled receptor 1 on the proliferation, migration, and adhesion of human ovarian cancer cells.

Downregulation of TGF-β1 Suppressed Proliferation and Increased Chemosensitivity of Ovarian Cancer Cells by Promoting BRCA1/Smad3 Signaling

CXCL12 Promotes Human Ovarian Cancer Cell Invasion Through Suppressing ARHGAP10 Expression.

Knockdown of Eif 4 E Suppresses Cell Proliferation , Invasion and Enhances Cisplatin Cytotoxicity in Human Ovarian Cancer Cells

TBL1XR1 promotes the migration and invasion of ovarian cancer cells by upregulating Wnt/β-catenin signaling pathway

PDCD4 Inhibits the Malignant Phenotype of Ovarian Cancer Cells

Chemokine CX3CL1/CX3CR1 biological axis promote ovarian cancer cell apotosis induced by platinum drug

Pro-survival Effects by NF-κB, Akt and ERK(1/2) and Anti-Apoptosis Actions by Six1 Disrupt Apoptotic Functions of TRAIL-Dr4/5 Pathway in Ovarian Cancer

Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27.

Long noncoding RNA AOC4P regulates tumor cell proliferation and invasion by epithelial-mesenchymal transition in gastric cancer.

Expression and clinical significance of Wnt3 a and TCF4 in human ovarian cancer

Down-regulation of GPR137 Expression Inhibits Proliferation of Colon Cancer Cells.

OCT4 Accelerates Tumorigenesis Through Activating JAK/STAT Signaling in Ovarian Cancer Side Population Cells

Deregulation of Angiopoietin-Like 4 Slows Ovarian Cancer Progression Through Vascular Endothelial Growth Factor Receptor 2 Phosphorylation